Cargando…
On the choice of Molnupiravir and Paxlovid as the only antivirals permitted for COVID-19 infection in Australia
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906570/ https://www.ncbi.nlm.nih.gov/pubmed/36752889 http://dx.doi.org/10.1007/s10238-023-01010-7 |